The PE Ratio as of December 2025 (TTM) for Genor Biopharma Holdings Limited (6998.HK) is 54.14

According to Genor Biopharma Holdings Limited’s latest financial reports and current stock price. The company's current PE Ratio is 54.14. This represents a change of -5692.62% compared to the average of -0.97 of the last 4 quarters.

Genor Biopharma Holdings Limited (6998.HK) Historical PE Ratio (quarterly & annually)

How has 6998.HK PE Ratio performed in the past?

The mean historical PE Ratio of Genor Biopharma Holdings Limited over the last ten years is -12.64. The current 54.14 PE Ratio has changed -42923.04% with respect to the historical average. Over the past ten years (40 quarters), 6998.HK's PE Ratio was at its highest in in the December 2024 quarter at 2.82. The PE Ratio was at its lowest in in the June 2019 quarter at -39.35.

Genor Biopharma Holdings Limited (6998.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Genor Biopharma Holdings Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genor Biopharma Holdings Limited (6998.HK) Average PE Ratio

How has 6998.HK PE Ratio performed in the past?

The current PE Ratio of Genor Biopharma Holdings Limited (6998.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Genor Biopharma Holdings Limited (6998.HK) PE Ratio vs. Peers

How is 6998.HK’s PE Ratio compared to its peers?

Genor Biopharma Holdings Limited’s PE Ratio is greater than Immunotech Biopharm Ltd (-6.15), greater than JW (Cayman) Therapeutics Co. Ltd (-1.96), greater than 3D Medicines Inc. (-6.79), greater than Zhaoke Ophthalmology Limited (-5.58), less than BioDlink International Company Limited (155.99), greater than Transcenta Holding Limited (-3.69), greater than Brii Biosciences Limited (-2.82), greater than Wuhan YZY Biopharma Co Ltd (-15.99), greater than Rici Healthcare Holdings Limited (5.77), greater than Sunho Biologics, Inc. (-11.52),

Build a custom stock screener for Genor Biopharma Holdings Limited (6998.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genor Biopharma Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genor Biopharma Holdings Limited (6998.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genor Biopharma Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.